Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.

Pennings ERA, Spanjaart AM, Thielen FW, Oerlemans S, Fleischer A, Sanges C, Gomes Da Silva M, Cabrerizo Y, Lecot P, Roux-Opstaele L, Dreuillet C, Gonzalez-Marcano E, Millán O, Jaeger U, Delgado J, Luu M, Huber B, Lorrain M, Pina M, Kremer A, Bolaños N, Clavreul S, Nier S, Liu RDK, Lissenberg-Witte BI, Anguille S, Robin M, Morris EC, Sureda A, Préau M, Pannard M, De Bock GH, Wagers SS, Negre H, Maucort-Boulch D, Hudecek M, Uyl-de Groot CA, Kersten MJ

Open source

DOI
10.1182/bloodadvances.2025017081
Published
2025 Dec 23
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025017081,
  title = {Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.},
  author = {Pennings ERA and Spanjaart AM and Thielen FW and Oerlemans S and Fleischer A and Sanges C and Gomes Da Silva M and Cabrerizo Y and Lecot P and Roux-Opstaele L and Dreuillet C and Gonzalez-Marcano E and Millán O and Jaeger U and Delgado J and Luu M and Huber B and Lorrain M and Pina M and Kremer A and Bolaños N and Clavreul S and Nier S and Liu RDK and Lissenberg-Witte BI and Anguille S and Robin M and Morris EC and Sureda A and Préau M and Pannard M and De Bock GH and Wagers SS and Negre H and Maucort-Boulch D and Hudecek M and Uyl-de Groot CA and Kersten MJ},
  year = {2025},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025017081},
  url = {https://doi.org/10.1182/bloodadvances.2025017081}
}

RIS

TY  - JOUR
TI  - Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.
AU  - Pennings ERA
AU  - Spanjaart AM
AU  - Thielen FW
AU  - Oerlemans S
AU  - Fleischer A
AU  - Sanges C
AU  - Gomes Da Silva M
AU  - Cabrerizo Y
AU  - Lecot P
AU  - Roux-Opstaele L
AU  - Dreuillet C
AU  - Gonzalez-Marcano E
AU  - Millán O
AU  - Jaeger U
AU  - Delgado J
AU  - Luu M
AU  - Huber B
AU  - Lorrain M
AU  - Pina M
AU  - Kremer A
AU  - Bolaños N
AU  - Clavreul S
AU  - Nier S
AU  - Liu RDK
AU  - Lissenberg-Witte BI
AU  - Anguille S
AU  - Robin M
AU  - Morris EC
AU  - Sureda A
AU  - Préau M
AU  - Pannard M
AU  - De Bock GH
AU  - Wagers SS
AU  - Negre H
AU  - Maucort-Boulch D
AU  - Hudecek M
AU  - Uyl-de Groot CA
AU  - Kersten MJ
PY  - 2025
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025017081
UR  - https://doi.org/10.1182/bloodadvances.2025017081
ER  -

APA

ERA, P., AM, S., FW, T., S, O., A, F., C, S., M, G. D. S., Y, C., P, L., L, R., C, D., E, G., O, M., U, J., J, D., M, L., B, H., M, L., M, P., A, K., N, B., S, C., S, N., RDK, L., BI, L., S, A., M, R., EC, M., A, S., M, P., M, P., GH, D. B., SS, W., H, N., D, M., M, H., CA, U. G., & MJ, K. (2025). Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.. Blood advances. https://doi.org/10.1182/bloodadvances.2025017081

Source records